Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Connor J. Hagen
Observed name:
Connor Hagen
Observed institutions:
Memorial Sloan Kettering Cancer Center,
University of Connecticut
ORCID:
0009-0000-2649-6284
Observed ORCID:
0009-0000-2649-6284
OpenAlex ID:
A5070693180
Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition
2020
·
Neeta Bala Tannan
, Mandana T. Manzari
, et al.
·
Blood
·
41
PDF
Broad Protection of Pigs against Heterologous PRRSV Strains by a GP5-Mosaic DNA Vaccine Prime/GP5-Mosaic rVaccinia (VACV) Vaccine Boost
2020
·
Junru Cui
, Caitlin M. O’Connell
, et al.
·
Vaccines
·
20
PDF
Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.
2022
·
Igor Odintsov
, Allan J.W. Lui
, et al.
·
Journal of Clinical Oncology
·
8
Abstract P233: TAS0953/HM06 is effective in preclinical models of diverse tumor types driven by RET alterations
2021
·
Igor Odintsov
, Renate I. Kurth
, et al.
·
Molecular Cancer Therapeutics
·
5
A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
·
Cancer Research Communications
·
4
PDF
Dual Inhibition of MCL1 and BCL2 in Lymphoma Using Tumor Targeted Nanoparticles
2019
·
Neeta Bala Bala
, Mandana Taghizadeh Manzari
, et al.
·
Blood
·
4
Evaluation of antigen agnostic anti-tumor activity and immune memory induced by CBX-15 (alphalex TM -MMAE) in the rat
2025
·
Timothy Paradis
, Qing Zhang
, et al.
·
Immunotherapy
Abstract B141: Evaluation of antigen-agnostic anti-tumor activity and immunological memory induced by CBX-15 (alphalexTM-MMAE) in the rat syngeneic breast cancer model
2023
·
Sophia Gayle
, Timothy Paradis
, et al.
·
Molecular Cancer Therapeutics
Data from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
FIGURE 2 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
Supplemental Table 1 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
Supplementary Figure S1 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
FIGURE 4 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
FIGURE 1 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
Supplementary Figure S2 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
Supplementary Figure S2 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
PDF
Data from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
Supplemental Table 2 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
FIGURE 3 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
FIGURE 3 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
Supplemental Table 1 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
FIGURE 1 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
Supplemental Table 3 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
Supplementary Figure S3 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
FIGURE 2 from A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
2023
·
M. Dorso
, Payal T. Patel
, et al.
Show more works
View as search
Works count:
31
Citation count:
82
H-index:
4
I10-index:
2
Year
Topic
Type